95457 ⎘
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings Peri-condensed systems
SENSOR-EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE
#2CRYSTALLINE INTERMEDIATES
#3COMPOUND, ORGANIC THIN FILM, PHOTOELECTRIC CONVERSION ELEMENT, IMAGE SENSOR, OPTICAL SENSOR AND SOLID-STATE IMAGING DEVICE
#4GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#5COMPOUNDS ATTACHABLE TO SKIN
#6NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF
#7COMPOUND, PHOTOELECTRIC DEVICE, LIGHT ABSORPTION SENSOR, SENSOR EMBEDDED DISPLAY PANEL, AND ELECTRONIC DEVICE
#8Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
#9MACROCYCLIC HETEROCYCLES AND USES THEREOF
#10ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#11OPTO-ELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
#12COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
#13METHODS OF MAKING LOW ODOR CHOLINE SALTS OF AN ORGANIC COMPOUND
#14COMPOUNDS FOR THE TREATMENT OF SARS
#15METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS
#16TETRACYCLIC COMPOUNDS AND METHODS FOR THE TREATMENT OF ZIKA VIRUS INFECTION
#17SENSOR-EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE
#18Glycosyl donor, preparation method therefor, and use thereof
#19Arylamine Compound and Use Thereof in Photoelectric Devices
#20Biologically active taxane analogs and methods of treatment by oral administration
#21Open-shell pi-conjugated molecules exhibiting multidimensional intermolecular covalency, compositions and process for preparing
#22USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES
#23Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS
#24METHODS OF MAKING LOW ODOR CHOLINE SALTS OF AN ORGANIC COMPOUND
#25Biologically active taxane analogs and methods of treatment by oral administration
#26Heripenes with pain-relieving effect, active substances of mycelium and the preparation method thereof, and pharmaceutical composition containing the heripenes or active substances
#27Biologically active taxane analogs and methods of treatment by oral administration
#28Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS
#29Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element
#30Methods of making low odor choline salts of an organic compound
#31Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
#32CYANATED BENZOXANTHENE AND BENZOTHIOXANTHENE COMPOUNDS
#33Method for the preparation of compounds having a 16-oxabicyclo[10.3.1]pentadecene scaffold and the subsequent products thereof
#34Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones
#35Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#36Biologically active taxane analogs and methods of treatment by oral administration
#37Compositions of protein receptor tyrosine kinase inhibitors
#38Cyanated benzoxanthene and benzothioxanthene compounds
#39USE OF ELLAGIC ACID DIHYDRATE IN PHARMACEUTICAL FORMULATIONS TO REGULATE BLOOD GLUCOSE LEVELS
#40Electroactive materials
#41Chlorinated napthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
#42Method for producing carboxylic acid anhydride, method for producing carboxylic imide, and method for manufacturing electrophotographic photosensitive member
#43TAXANE COMPOUNDS, COMPOSITIONS AND METHODS
#44Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#45Methods of modulating compliance of the trabecular meshwork
#46TAXANE AND ABEO-TAXANE ANALOGS
#47Compound and organic light-emitting device including the same
#48Organic light emitting element
#49Photoelectric conversion element and solid-state imaging device
#50Organic compound and photovoltaic device comprising the same
#51Perylenemonoimide and naphthalenemonoimide derivatives and their use in dye-sensitized solar cells
#52ANTIVIRAL COMPOUNDS
#536,12-dioxaanthanthrene derivative, organic semiconductor element, and method for manufacturing organic semiconductor element
#54Compositions of protein receptor tyrosine kinase inhibitors
#55Chartreusin analogues
#56Taxane and abeo-taxane analogs
#57Photochromic fluorenopyrans with defined dibenzo[B,D]pyrano fused attachment
#58Glioblastoma inhibiting compounds and their use
#59DIOXAANTHANTHRENE COMPOUND AND ELECTRONIC DEVICE
#60Condensed cyclic compound and organic light emitting device including the same
#61Organic electroluminescence element
#62Organic electroluminescent element, material for organic electroluminescent element and light emitting device, display device, and illumination device, each employing organic electroluminescent element
#63Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
#64Bibenzo[B]furan compound, photoelectric conversion material, and photoelectric conversion element
#65Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#66Taxane compounds, compositions and methods
#67Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element
#68Compounds that Modulate Store Operated Calcium Channels
#69Organic electroluminescence element, illumination device and display device
#70Materials for organic electroluminescence devices
#71Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
#72Methods of modulating compliance of the trabecular meshwork
#73Solid forms of ortataxel
#74Taxane and abeo-taxane analogs
#75Biologically active taxane analogs and methods of treatment by oral administration
#76Method for producing organic transistor, organic transistor, method for producing semiconductor device, semiconductor device, and electronic apparatus
#77Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#78Organic electroluminescent element, material for organic electroluminescent element, and light emitting device, display device and illumination device each using the element
#79Photoelectric conversion element and solid-state imaging device
#80Anthanthrene based compound and semiconductor device
#81Biologically active taxane analogs and methods of treatment by oral administration
#82ORGANIC ELECTROLUMINESCENT DEVICE AND LIGHT-EMITTING POLYMER COMPOSITION
#83Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#84Xanthene based semiconductor compositions
#85Organic compound and photovoltaic device comprising the same
#86Taxane compounds, compositions and methods
#87Semiconducting composition
#88Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
#89Fluorination of organic compounds
#90Compositions of protein receptor tyrosine kinase inhibitors
#91Poly(oxyalkylene)ated colorants and their use as fluorescent security taggants
#92Biologically active taxane analogs and methods of treatment by oral administration
#93SOLID FORMS OF ORTATAXEL
#94ANTHANTHRENE BASED COMPOUND AND SEMICONDUCTOR DEVICE
#95Biologically active taxane analogs and methods of treatment
#96Polyketal compounds, synthesis, and applications
#97Biologically active taxane analogs and methods of treatment
#98Terrylene and quaterrylene derivatives
#99Genipin derivatives and uses thereof
#100Skin lightening compositions with acetylcholinesterase inhibitors
#101Novel enrichment methods for gallic acid esters including 1-O-galloy1-bata-D-glucose and mucic acid gallates medicaments, therapeutic applications and methods of treatment thereof
#102Materials for organic electroluminescent devices
#103Wortmannin conjugates and uses thereof
#104Novel hybride materials and related methods and devices
#105Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
#106DIOXAANTHANTHRENE COMPOUND AND SEMICONDUCTOR DEVICE
#107Materials for organic electroluminescent devices
#108N,N'-BIS(FLUOROPHENYLALKYL)-SUBSTITUTED PERYLENE-3,4:9,10-TETRACARBOXIMIDES, AND THE PREPARATION AND USE THEREOF
#109DEGRANULATION INHIBITOR
#110Materials for organic electroluminescence devices
#1116-MEMBER RING STRUCTURE USED IN ELECTROLUMINESCENT DEVICES
#112Compositions and methods for treatment of liver disease
#113Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
#114Biologically active taxane analogs and methods of treatment
#115Terrylene and quaterrylene derivatives
#116Biologically active taxane analogs and methods of treatment
#117Biologically Active Taxane Analogs and Methods of Treatment
#118Poly(oxyalkylene)ated colorants and their use as fluorescent security taggants
#119Substituted rylene derivatives
#120Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1
#121METHOD FOR PRODUCING ORGANIC FIELD-EFFECT TRANSISTORS
#122Method for producing organic field-effect transistors
#123Genipin derivatives and uses thereof
#124Naphthalene derivatives and colorants for keratin fibers containing these compounds
#125Novel antibacterial agents
#126Cytotoxic agents comprising new taxanes
#127Genipin derivatives and uses thereof
#128Intermediates for aromatic polyketides as selective anticancer and antiviral agents
#129Compounds and methods for inhibiting cellular responses to hypoxia
#130Light-emitting device, condensed polycyclic compound used therein and method for producing same
#131Method of treating diabetes and obesity using carbohydrate absorption inhibitors